+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Experimental gene therapy for gliomas by both replication-competent and replication-defective herpes simplex viruses



Experimental gene therapy for gliomas by both replication-competent and replication-defective herpes simplex viruses



Society for Neuroscience Abstracts 23(1-2): 2447




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031366035

Download citation: RISBibTeXText


Related references

Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses. Prostate 53(2): 95, 2002

Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses. Journal of Gene Medicine 8(5): 603-615, 2006

Comparing gene transduction and viral replication within large subcutaneous human glioma inoculated with a replication-defective versus a replication-conditional herpes simplex virus type I vector. Cancer Gene Therapy 5(6 CONF Suppl. ): S11, 1998

Intravesical oncolytic viral gene therapy using attenuated, replication-competent, herpes simplex viruses G207 and NV1020 is highly effective in the treatment of bladder cancer in an orthotopic syngeneic model. Journal of Urology 163(4 Suppl ): 118, 2000

Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector. Annals of Surgery 228(3): 366-374, 1998

Replication competent, avirulent Herpes simplex virus as a vector for neural and ocular gene therapy. Official Gazette of the United States Patent & Trademark Office Patents 1237(4), 2000

Oncolytic virotherapy using replication-competent herpes simplex viruses. Uirusu 57(1): 57-65, 2007

In vitro gene therapy of hepatocellular carcinoma using replication-defective and tumor-specific replication-competent adenovirus carrying interleukin-12 gene. Zhonghua Zhong Liu Za Zhi 26(10): 581-584, 2004

In vitro gene therapy of hepatocellular carcinoma using replication-defective and tumor-specific replication-competent adenovirus carrying interleukin-12 gene. Zhonghua Zhongliu Zazhi 26(10): 581-584, 2004

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. Human Gene Therapy 10(17): 2741-2755, 1999

Efficient TK/GCV-based gene therapy against B-CLL mediated by replication-defective herpes simplex virus-1. Blood 96(11 Part 2): 296b, 2000

Suicide gene therapy of C6 glioma cells mediated by replication-deficient and replication-competent vaccinia viruses. Cancer Gene Therapy 10(Suppl. 1): S32, 2003

Experimental gene therapy of gliomas by herpes simplex viruses. Journal of Neurochemistry 69(Suppl. ): S131, 1997

Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model. Faseb Journal 15(7): 1306-1308, 2001

A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine. Journal of Virology 82(17): 8431-8441, 2008